CLINICAL COURSES OF RESIDUAL OR RECURRENT CASES UNDERGO-ING ENDOSCOPIC MUCOSAL RESECTION FOR EARLY GASTRIC CANCER

DOI
  • AKAMATSU Taiji
    Second Department of Internal Medicine, Shinshu University School of Medicine
  • MIYATA Kazunobu
    Department of Laboratory Medicine, Shinshu University School of Medicine
  • OWA Tsutomu
    Department of Laboratory Medicine, Shinshu University School of Medicine
  • USHIMARU Hiroyasu
    Department of Laboratory Medicine, Shinshu University School of Medicine
  • HASEBE Osamu
    Department of Laboratory Medicine, Shinshu University School of Medicine
  • MUKAWA Kenji
    Department of Laboratory Medicine, Shinshu University School of Medicine
  • SHIMIZU Toshiki
    Department of Laboratory Medicine, Shinshu University School of Medicine
  • HARA Etsuo
    Department of Laboratory Medicine, Shinshu University School of Medicine
  • MAEJIMA Shinya
    Department of Laboratory Medicine, Shinshu University School of Medicine
  • KIYOSAWA Kendo
    Department of Laboratory Medicine, Shinshu University School of Medicine
  • FURUTA Seiichi
    Department of Laboratory Medicine, Shinshu University School of Medicine
  • KATSUYAMA Tsutomu
    Department of Laboratory Medicine, Shinshu University School of Medicine

Bibliographic Information

Other Title
  • 早期胃癌に対する内視鏡的治療の問題点とその対策―遺残・再発例26例の臨床経過―

Search this article

Abstract

Clinical courses of 26 cases who were recognized to have residue (11 cases) or recurrence (15 cases) of cancer after endoscopic mucosal resection for early gastric cancer were retrospectively studied. Four of 26 cases (15.4%) underwent surgical gastrectomy, and other 22 cases (84.6%) were retreated by endoscopic procedures; 14 cases were treated by endoscopic mucosal resection, 7 by cauterization with high-frequent current, 1 by endoscopic local injection of OK-432. Finally 16 of 22 cases (72.7%) were cured, while the other 6 cases (27.3%) were not cured. Three (13.6%) of these non cured 6 cases are now receiving treatment, and 1 case (4.5%) died of pneumonia during repeat endoscopic treatment, and in the remaining 2 cases (9.1%) the lesions developed into advanced cancer because of inadequate follow-up and rapid growth of tumor. Generally surgical gastor-ectomy should be recommended for residual or recurrent lesions after endoscopic mucosal resection because of the possibility of lymph node metastasis. When residual or recurrent lesions are retreated by endoscopic procedures, we should decide it after evaluating physical status of patients and histological atipia of cancer.

Journal

Details 詳細情報について

Report a problem

Back to top